These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37321723)

  • 1. Oral pectin/oligochitosan microspheres for colon-specific controlled release of quercetin to treat inflammatory bowel disease.
    Jing S; Chen H; Liu E; Zhang M; Zeng F; Shen H; Fang Y; Muhitdinov B; Huang Y
    Carbohydr Polym; 2023 Sep; 316():121025. PubMed ID: 37321723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
    Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
    Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
    Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart Responsive Quercetin-Conjugated Glycol Chitosan Prodrug Micelles for Treatment of Inflammatory Bowel Diseases.
    Shen C; Zhao L; Du X; Tian J; Yuan Y; Jia M; He Y; Zeng R; Qiao R; Li C
    Mol Pharm; 2021 Mar; 18(3):1419-1430. PubMed ID: 33522827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factorial design-based development of measlamine microspheres for colonic delivery.
    Jain V; Prasad D; Jain D; Mishra SK; Singh R
    Biomatter; 2011; 1(2):182-8. PubMed ID: 23507747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
    Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI
    Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-oligochitosan-pectin microcarrier for colonic drug delivery.
    Stealey S; Guo X; Majewski R; Dyble A; Lehman K; Wedemeyer M; Steeber DA; Kaltchev MG; Chen J; Zhang W
    Pharm Dev Technol; 2020 Feb; 25(2):260-265. PubMed ID: 31709858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.
    Hua S; Marks E; Schneider JJ; Keely S
    Nanomedicine; 2015 Jul; 11(5):1117-32. PubMed ID: 25784453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of Lactiplantibacillus plantarum by colon-targeted adhesive pectin microspheres: Effects of pectin methyl esterification degrees.
    Xu D; Zhao X; Mahsa GC; Ma K; Zhang C; Rui X; Dong M; Li W
    Carbohydr Polym; 2023 Aug; 313():120874. PubMed ID: 37182964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease.
    Qiao H; Fang D; Chen J; Sun Y; Kang C; Di L; Li J; Chen Z; Chen J; Gao Y
    Drug Deliv; 2017 Nov; 24(1):233-242. PubMed ID: 28156160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon-targeting of progesterone using hybrid polymeric microspheres improves its bioavailability and in vivo biological efficacy.
    Gadalla HH; Mohammed FA; El-Sayed AM; Soliman GM
    Int J Pharm; 2020 Mar; 577():119070. PubMed ID: 31981708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally Administrated Olsalazine-Loaded Multilayer Pectin/Chitosan/Alginate Composite Microspheres for Ulcerative Colitis Treatment.
    Li J; Pu Y; Li S; He B; Chen J
    Biomacromolecules; 2023 May; 24(5):2250-2263. PubMed ID: 37068182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pectin-based microspheres for colon-specific delivery of vancomycin.
    Bigucci F; Luppi B; Monaco L; Cerchiara T; Zecchi V
    J Pharm Pharmacol; 2009 Jan; 61(1):41-6. PubMed ID: 19126295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronidazole loaded pectin microspheres for colon targeting.
    Vaidya A; Jain A; Khare P; Agrawal RK; Jain SK
    J Pharm Sci; 2009 Nov; 98(11):4229-36. PubMed ID: 19492406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease.
    Lyu YL; Zhou HF; Yang J; Wang FX; Sun F; Li JY
    Mediators Inflamm; 2022; 2022():5665778. PubMed ID: 35915741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of quercetin against acetic acid induced inflammatory bowel disease (IBD) like symptoms in rats: possible morphological and biochemical alterations.
    Dodda D; Chhajed R; Mishra J
    Pharmacol Rep; 2014 Feb; 66(1):169-73. PubMed ID: 24905324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
    Newton AM; Lakshmanan P
    Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Efficacy of Chitosan, Pectin Based Mesalamine Colon Targeted Drug Delivery Systems on TNBS-induced IBD Model Rats.
    Newton AMJ; Lakshmanan P
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):113-127. PubMed ID: 30657050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
    Sareen R; Jain N; Rajkumari A; Dhar KL
    Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.